Jennifer Michaelson - Apr 18, 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Development Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Apr 18, 2023
Transactions value $
-$2,549
Form type
4
Date filed
4/20/2023, 04:32 PM
Previous filing
Apr 14, 2023
Next filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$2.55K -238 -0.26% $10.71 90.9K Apr 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.